EW vs QDEL: fair value comparison
Edwards Lifesciences Corporation and QuidelOrtho Corporation · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, EW currently sits closer to the top of our discount ranking. EW carries the stronger quality grade.
| EW | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $89.90 | $17.71 |
| 12-month range | $81.26–$90.74 | $12.64–$31.25 |
| Sector rank | #50 of 113 Healthcare | #51 of 113 Healthcare |
| Quality grade | A | F |
| Leverage | Low | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: EW fair value analysis · QDEL fair value analysis